We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

RCEL Avita Medical Inc

0.06 (0.53%)
Last Updated: 10:01:12
Delayed by 15 minutes


Draw Mode:

Volume 42,185
Bid Price 11.30
Ask Price 11.35
News (1)
Share Name Share Symbol Market Stock Type
Avita Medical Inc RCEL NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
0.06 0.53% 11.30 10:01:12
Open Price Low Price High Price Close Price Previous Close
11.26 11.14 11.7285 11.24
Trades Shares Traded VWAP Financial Volume Average Volume
620 42,185  11.40  480,764 -
Last Trade Type Quantity Price Currency
10:08:15 1  11.325 USD

Avita Medical Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.04B 91.38M - 37.64M -26.67M -0.29 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News Avita Medical

Date Time Source Heading
12/04/202308:00GlobeNewswire Inc.AVITA Medical to Host Investor Webinar Briefing
11/21/202315:15GlobeNewswire Inc.AVITA Medical to Present at the Piper Sandler 35th Annual..
11/21/202308:10IH Market NewsKeep An Eye Out: Pre-Market Movers And Analyst..
11/20/202315:15GlobeNewswire Inc.AVITA Medical Updates Full Year 2023 Guidance
11/09/202315:09Edgar (US Regulatory)Form 8-K - Current report
11/09/202315:07Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202315:01GlobeNewswire Inc.AVITA Medical Reports Third Quarter Financial Results with..
11/09/202308:00GlobeNewswire Inc.AVITA Medical Announces Distribution Partnership with..
10/23/202315:36Edgar (US Regulatory)Form 8-K - Current report
10/19/202315:05GlobeNewswire Inc.AVITA Medical to Announce Third Quarter 2023 Financial..
10/18/202308:07Edgar (US Regulatory)Form 8-K - Current report
10/18/202308:04Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No RCEL Message Board. Create One! See More Posts on RCEL Message Board See More Message Board Posts

RCEL Historical

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.
3 Months0.
6 Months0.
1 Year0.
3 Years0.
5 Years0.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the U.S. with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 U.S. burn centres. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the U.S. region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |